No Data
Seres Therapeutics Gains Amid Takeover Speculation
Seres Therapeutics Rumor Highlighted in Betaville Blog
Express News | Watching Seres Therapeutics; Traders Circulate M&A Blog Unconfirmed Rumor That Nestle Has Said To Have Made A Bid Between $6.90-$7.20/Share
Institutions Along With Retail Investors Who Hold Considerable Shares InSeres Therapeutics, Inc. (NASDAQ:MCRB) Come Under Pressure; Lose 12% of Holdings Value
Seres Therapeutics Files Registration for Resale of Shares by Societe Des Produits Nestle
Express News | Seres Therapeutics Files Prospectus Related to Resale,From Time to Time, of up to 14.3 Mln Shares of Common Stock by Selling Stockholder- SEC Filing